9-ING-41 in Patients with Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University Hospital, Ghent
Corcept Therapeutics
Celgene
Western Regional Medical Center
Incyte Corporation